HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
When people are injured or have a cut, the body typically heals itself by creating a blood clot. Blood clots consist of platelets and are formed through a process called coagulation. The body naturally breaks down these blood clots as it heals. However, those diagnosed with a blood clotting disorder cannot properly create or break down blood clots, causing the clots to form anywhere in the body. This can potentially block arteries and veins, making it harder for the body to carry blood away from and to the heart, brain, and other organs.
Regional Cancer Care Associates specializes in treating many blood clotting disorders, including phlebitis, thrombophilia, deep vein thrombosis, and pulmonary embolisms. With more than 20 locations across New Jersey, Connecticut, Maryland, and the Washington, DC area, we can assist those with a blood clotting disorder with an accurate diagnosis and effective treatment.
We’re here for you. Call us at 844-346-7222 or
Many patients diagnosed with a blood clotting disorder have the condition from birth, inheriting it from one or both parents. Patients can also develop a blood clotting disorder following surgical procedures and as a result of certain medical conditions, medications, or situations, including:
People with a blood clotting disorder are at increased risk of blood clots forming and moving to areas of the body where they can cause serious illness and even death. Once blood clots form in the blood vessels, they can travel to areas such as the kidneys, limbs, heart, brain, or lungs. Patients can experience varying symptoms depending on the location of the blood clot. For example:
While hereditary hemochromatosis is the most common iron overload disorder, there are other forms of the condition, including:
Different clotting disorders alter blood clot production in varying ways. Some disorders cause the body to create too many blood clots, while others prevent them from forming. This second group, often termed bleeding disorders, includes hemophilia and Von Willebrand Disease. The most common types of blood clotting disorders include:
To properly diagnose a blood clot disorder, physicians consider the patient’s medical history and family medical history. This can determine if a patient is predisposed to a blood clotting disorder. After a thorough physical examination, physicians may order one or more of several tests, including:
The hematology physicians at Regional Cancer Care Associates have extensive experience in diagnosing and treating the full range of blood clotting disorders. The medical team provides care at more than 20 locations in New Jersey, Connecticut, Maryland, and the Washington, DC area. To learn more about our diagnosis and treatment process, contact us today.
RCCA offers cutting-edge treatment options for every type of cancer. Our expert care teams can match you with the treatment plan that fits your needs. LEARN MORE
Improve your quality of life and learn to manage life with cancer through our integrative services. We offer several solutions to support and promote physical, mental, emotional, and spiritual health. LEARN MORE
The field of cancer treatment is constantly improving and evolving. RCCA conducts hundreds of clinical trials that can help develop new therapies and treatment plans. LEARN MORE
If you need near-term or ongoing care for anemia or another benign blood disorder, schedule an appointment at Regional Cancer Care Associates. Patients have access to a full range of services across New Jersey, Connecticut, Maryland, and the Washington, DC area, making it easy to find a location convenient for you. Contact us today to learn more about our benign hematology services.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.